[go: up one dir, main page]

CY1117906T1 - Μεθοδος καθαρισμου για υδατανθρακα απο στρεπτοκοκκο ομαδας α - Google Patents

Μεθοδος καθαρισμου για υδατανθρακα απο στρεπτοκοκκο ομαδας α

Info

Publication number
CY1117906T1
CY1117906T1 CY20161100708T CY161100708T CY1117906T1 CY 1117906 T1 CY1117906 T1 CY 1117906T1 CY 20161100708 T CY20161100708 T CY 20161100708T CY 161100708 T CY161100708 T CY 161100708T CY 1117906 T1 CY1117906 T1 CY 1117906T1
Authority
CY
Cyprus
Prior art keywords
streetcock
group
cleaning carbon
carbohydrate
gas
Prior art date
Application number
CY20161100708T
Other languages
English (en)
Inventor
Paolo Costantino
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of CY1117906T1 publication Critical patent/CY1117906T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Μέθοδος καθαρισμού υδατάνθρακα GAS Streptococcus pyogenes που περιλαμβάνει στάδιο χρωματογραφίας ανιονικής εναλλαγής. Η μέθοδος παρέχει καλή απόδοση του GAS υδατάνθρακα. Τα σακχαρίδια της εφεύρεσης έχουν χαμηλά επίπεδα υαλουρονικού οξέος, πρωτεΐνης και νουκλεϊνικού οξέος μόλυνσης.
CY20161100708T 2008-10-27 2016-07-19 Μεθοδος καθαρισμου για υδατανθρακα απο στρεπτοκοκκο ομαδας α CY1117906T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10876308P 2008-10-27 2008-10-27
PCT/IB2009/007346 WO2010049806A1 (en) 2008-10-27 2009-10-27 Purification method

Publications (1)

Publication Number Publication Date
CY1117906T1 true CY1117906T1 (el) 2017-05-17

Family

ID=41692891

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100708T CY1117906T1 (el) 2008-10-27 2016-07-19 Μεθοδος καθαρισμου για υδατανθρακα απο στρεπτοκοκκο ομαδας α

Country Status (16)

Country Link
US (1) US11065323B2 (el)
EP (1) EP2349520B1 (el)
JP (1) JP5689064B2 (el)
CN (1) CN102264444B (el)
AU (1) AU2009309416B2 (el)
BR (1) BRPI0920524A2 (el)
CA (1) CA2777837C (el)
CY (1) CY1117906T1 (el)
DK (1) DK2349520T3 (el)
ES (1) ES2586308T3 (el)
HR (1) HRP20160815T1 (el)
HU (1) HUE029265T2 (el)
PL (1) PL2349520T3 (el)
PT (1) PT2349520T (el)
SI (1) SI2349520T1 (el)
WO (1) WO2010049806A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202192401A1 (ru) 2019-04-02 2022-03-30 Ваксайт, Инк. Оптимизированный бесклеточный синтез плазмидного антигена инвазии в и родственные композиции и способы применения
KR20220143107A (ko) 2020-02-18 2022-10-24 박사이트, 인코포레이티드 폴리사카라이드-단백질 접합체를 갖는 그룹 a 스트렙 면역원성 조성물
JP2024506713A (ja) * 2021-02-17 2024-02-14 バックスサイト・インコーポレイテッド 多糖およびそのポリペプチドコンジュゲートの精製方法

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4882317A (en) 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IT1187753B (it) 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
ATE107703T1 (de) * 1986-04-16 1994-07-15 Brigham & Womens Hospital Bakterielle antigene, antikörper, impfstoffe und deren herstellung.
EP0346467A4 (en) * 1987-12-26 1990-11-28 Kyowa Hakko Kogyo Co., Ltd. Process for purifying hyaluronic acid
US5204098A (en) 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
US5001112A (en) * 1988-04-12 1991-03-19 Bristol-Myers Company Antitumor antibiotic kedarcidin
NL8802046A (nl) 1988-08-18 1990-03-16 Gen Electric Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
DE3841091A1 (de) 1988-12-07 1990-06-13 Behringwerke Ag Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
CA2006700A1 (en) 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
JPH04506662A (ja) 1989-07-14 1992-11-19 アメリカン・サイアナミド・カンパニー 接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー
JPH0346467A (ja) * 1989-07-14 1991-02-27 Hitachi Ltd 映像信号切換回路
IT1237764B (it) 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
EP0471177B1 (en) 1990-08-13 1995-10-04 American Cyanamid Company Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5252457A (en) * 1991-10-08 1993-10-12 Eastman Kodak Company Wash composition containing signal stop reagent, test kit and method of use with peroxidase-labeled specific binding ligand
IT1262896B (it) 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
US5866135A (en) 1994-04-21 1999-02-02 North American Vaccine, Inc. Group A streptococcal polysaccharide immunogenic compositions and methods
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
BR9608612A (pt) 1995-06-07 1999-05-04 Smithkline Beecham Biolog Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
US5997881A (en) * 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
EP1801217A1 (en) 1997-09-12 2007-06-27 The University of Tennessee Research Foundation Group A streptococcal vaccines
DE69841807D1 (de) 1997-11-06 2010-09-16 Novartis Vaccines & Diagnostic Neisseriale antigene
BR9814878A (pt) 1997-11-21 2000-10-03 Genset Sa Sequência genÈmica e polipeptìdeos de chlamydia pneumoniae, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
EP1032676A2 (en) 1997-11-28 2000-09-06 Genset $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
CN1224708C (zh) 1998-01-14 2005-10-26 启龙股份公司 脑膜炎奈瑟氏球菌抗原
US7018637B2 (en) 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
MX343744B (es) 1998-05-01 2016-11-22 J Craig Venter Inst Inc Antigenos de neisseria meningitidis y composiciones que los contienen.
KR100704826B1 (ko) 1998-08-19 2007-04-09 박스터 헬쓰케어 에스.에이. Ｎ-아크릴로일화된 폴리사카라이드를 사용하여 제조된백신으로서 사용하기에 적합한 면역원성β-프로피온아미도-결합 폴리사카라이드 단백질 컨쥬게이트
EP1144998A3 (en) 1998-10-09 2002-08-07 Chiron Corporation Neisseria genomic sequences and methods of their use
EP1133572A4 (en) 1998-11-12 2005-06-15 Univ California GENOMIC SEQUENCE OF CHLAMYDIA PNEUMONIAE
AU1626199A (en) 1998-12-04 2000-06-26 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The A vi-repa conjugate vaccine for immunization against salmonella typhi
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
HU228499B1 (en) 1999-03-19 2013-03-28 Smithkline Beecham Biolog Streptococcus vaccine
EP1165796A2 (en) 1999-04-09 2002-01-02 Techlab, Inc. Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
CA2397508C (en) 2000-01-17 2015-11-24 Chiron Spa Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
GB0007432D0 (en) 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
DE60139690D1 (de) 2000-07-03 2009-10-08 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
NZ583028A (en) 2000-10-27 2011-10-28 Novartis Vaccines & Diagnostic Nucleic acids and proteins from streptococcus groups A & B
AU2002309706A1 (en) 2001-05-11 2002-11-25 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
US20020192205A1 (en) * 2001-05-11 2002-12-19 Francis Michon Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
WO2004011027A1 (en) 2002-07-30 2004-02-05 Baxter International Inc. Chimeric multivalent polysaccharide conjugate vaccines
AU2003260102A1 (en) 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
US20070036828A1 (en) 2002-09-13 2007-02-15 Chiron Corporation Group b streptococcus vaccine
GB0502095D0 (en) 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
HUE056842T2 (hu) 2005-06-27 2022-03-28 Pfizer Ireland Pharmaceuticals Immunogén készítmény
US8598337B2 (en) 2006-01-13 2013-12-03 Baxter International Inc. Method for purifying polysaccharides
EP2436700B8 (en) 2007-03-23 2018-08-01 Wyeth LLC Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides

Also Published As

Publication number Publication date
JP5689064B2 (ja) 2015-03-25
CA2777837A1 (en) 2010-05-06
SI2349520T1 (sl) 2016-08-31
AU2009309416A1 (en) 2010-05-06
HUE029265T2 (en) 2017-02-28
DK2349520T3 (en) 2016-08-15
AU2009309416B2 (en) 2015-05-28
HRP20160815T1 (hr) 2016-09-23
BRPI0920524A2 (pt) 2015-12-22
CA2777837C (en) 2017-07-11
PT2349520T (pt) 2016-08-16
CN102264444B (zh) 2015-08-05
EP2349520A1 (en) 2011-08-03
US11065323B2 (en) 2021-07-20
ES2586308T3 (es) 2016-10-13
WO2010049806A1 (en) 2010-05-06
EP2349520B1 (en) 2016-05-25
PL2349520T3 (pl) 2017-08-31
JP2012506853A (ja) 2012-03-22
CN102264444A (zh) 2011-11-30
US20120010398A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
EP4105644A3 (en) Systems and devices for sequence by synthesis analysis
WO2016161375A3 (en) Methods of using oligonucleotide-guided argonaute proteins
WO2011012316A3 (de) Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression
WO2014162307A3 (en) Methods and apparatus for synthesizing nucleic acids
IN2012DN00403A (el)
WO2009103027A3 (en) Methods for in vitro joining and combinatorial assembly of nucleic acid molecules
WO2010127304A3 (en) Sequencing methods
DK1928901T3 (da) Polypeptider, der har beta-glucosidaseaktivitet og polynukleotider, der koder for samme
EA201490534A1 (ru) Способы мечения днк-кодированных библиотек
EP4026901A3 (en) Method for screening alpha-amylases
WO2007075626A3 (en) Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments
DK2668267T3 (da) Polypeptider med cellobiohydrolaseaktivitet og polynukleotider, som koder for dem
SG10201408300PA (en) Processing of amplified dna fragments for sequencing
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
TR201815882T4 (tr) Tal efektörü aracılı dna modifikasyonu.
TW200740841A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
WO2009124255A8 (en) Methods for transcript analysis
AU2009236219A8 (en) Silencing of CSN5 gene expression using interfering RNA
WO2012104399A3 (en) Device and method for the generation of molecular microarrays
BRPI1009576A2 (pt) anticorpo, molécula de anticorpo neutralizadora, sequência de dna isolada, vetor de clonagem ou expressão, célula hospedeira, processo para a produção do anticorpo, composição farmacêutica, uso de um anticorpo, e, método para o tratamento de um paciente.
NZ612285A (en) Enhanced immune response in bovine species
WO2010135836A8 (en) Novel beta-glucosidase enzymes
MY189932A (en) Recombinant microorganism for improved production of alanine
WO2011160052A3 (en) Methods and compositions for sequence specific rna endonucleases
CY1110024T1 (el) Πολυπεπτιδια που εχουν αντιμικροβιακη δραστικοτητα και πολυνουκλεοτιδια που τα κωδικοποιουν